Which describes you?


Product?

Do you need to know more about what we offer for each of our products?

Do you want to know more about LUCENTIS Access Solutions? To see what we offer, click here.

The information contained in this section of the site is for U.S. health care professionals only. Please click "OK" if you are a U.S. health care professional.

The link you selected will take you away from this site to one that is not owned or controlled by Genentech. Genentech is not part of the site. Nor does it control the content. Genentech does not guarantee the information on the page. Your use of third-party websites is at your own risk and is subject to the terms and conditions of use for such sites. 


About Us


LUCENTIS Access Solutions: connecting patients to the medicine they need.

We are committed to helping all patients access our medicines, regardless of their ability to pay. Our dedicated staff of Specialists can help:

  • Resolve benefits and coverage issues
  • Find co-pay assistance for underinsured patients
  • Provide free medicine for eligible uninsured patients through the Genentech® Access to Care Foundation (GATCF)
  • Individualize services to meet your patients' specific needs

Since 1985, when its first product was approved, Genentech has donated approximately $1.5 billion in free medicine to uninsured patients through GATCF and other product donation programs. In addition, Genentech has donated approximately $250 million to various independent, non-profit organizations for co-pay assistance since 2005.

LUCENTIS Access Solutions helps to resolve specific access and reimbursement issues for individual patients every day. Our dedicated Specialists help bring patient treatment and practice solutions together.

Who is LUCENTIS for?

LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with Wet Age-Related Macular Degeneration (AMD) and Macular Edema Following Retinal Vein Occlusion (RVO).

What important safety information should I know about LUCENTIS?

LUCENTIS is a prescription medication given by injection into the eye, and it has side effects. Some LUCENTIS patients have had detached retinas and serious eye infections. LUCENTIS should not be used in patients who have an infection in or around the eye or are allergic to LUCENTIS or any of its ingredients. LUCENTIS patients have had increases in eye pressure within 1 hour of an injection. Serious side effects also include inflammation inside the eye, and rarely, problems related to the injection procedure, such as cataracts. Although not common, some LUCENTIS patients have had strokes or heart attacks. If your eye becomes red, sensitive to light, painful, or has a change in vision, you should call or visit your eye doctor right away. Ask your doctor if you have questions or want more information.

For additional safety information, please talk to your doctor and see the LUCENTIS full prescribing information.

LUCENTIS® is a registered trademark and the Access Solutions logo and the Access Solutions Treatment made possible logo are trademarks of Genentech USA, Inc.

Who is LUCENTIS for?

LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with Wet Age-Related Macular Degeneration (AMD) and Macular Edema Following Retinal Vein Occlusion (RVO).

What important safety information should I know about LUCENTIS?

LUCENTIS is a prescription medication given by injection into the eye, and it has side effects. Some LUCENTIS patients have had detached retinas and serious eye infections. LUCENTIS should not be used in patients who have an infection in or around the eye or are allergic to LUCENTIS or any of its ingredients. LUCENTIS patients have had increases in eye pressure within 1 hour of an injection. Serious side effects also include inflammation inside the eye, and rarely, problems related to the injection procedure, such as cataracts. Although not common, some LUCENTIS patients have had strokes or heart attacks. If your eye becomes red, sensitive to light, painful, or has a change in vision, you should call or visit your eye doctor right away. Ask your doctor if you have questions or want more information.

For additional safety information, please talk to your doctor and see the LUCENTIS full prescribing information.

LUCENTIS® is a registered trademark and the Access Solutions logo and the Access Solutions Treatment made possible logo are trademarks of Genentech USA, Inc.

Health Care Professional
Genentech Access Solutions can assist in managing the patients you refer to us. However, the use of our forms and the accuracy of the information provided are your responsibility and not that of Genentech Access Solutions.

Patient / Caregiver
Genentech Access Solutions can help you in getting the medicine you need. However, it is up to your doctor's office to provide accurate information when filling out our forms.

© 2010 Genentech USA, Inc. All rights reserved. This site is intended for U.S. residents only.